drug
pegaspargase
Marketedupdated 3mo agoby Servier Pharmaceuticals LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying pegaspargase
- phase2SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma
- phase2A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
- phase3Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma
- phase3Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
- phase1Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
- phase3Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
- phase2Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
- phase3A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 14m ago
Found something off?
comments(0)
5-min edit window · permanent after that